![risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. “Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1 Thyroid Cancer Human Data:](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3139055092816828788)
risk of medullary thyroid cancer with glp 1
Shipping Estimate
risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. “Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1 Thyroid Cancer Human Data:
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
![risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1 Thyroid Cancer Human Data:](https://www.diabetesincontrol.com/wp-content/uploads/2026/03/glp1-thyroid-cancer-human-data-research.png)
![risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1 Thyroid Cancer Human Data:](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3925144602533607630)
![risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1 Thyroid Cancer Human Data:](https://www.mayoclinic.org/-/media/kcms/gbs/medical-professionals/images/2025/08/15/16/24/glp-1ra-767x535.jpg)
![risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1 Thyroid Cancer Human Data:](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3950686998050511725)
![risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1 Thyroid Cancer Human Data:](https://substackcdn.com/image/fetch/$s_!HMuO!,w_1200,h_675,c_fill,f_jpg,q_auto:good,fl_progressive:steep,g_auto/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fbcfe7493-4d49-4e99-9e67-06dc574d46b3_993x695.png)
![risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1 Thyroid Cancer Human Data:](https://www.mdpi.com/biomolecules/biomolecules-14-00687/article_deploy/html/images/biomolecules-14-00687-g002.png)
